Apollo 24/7 secures Rs 2,475 cr investment and 12.1% Advent stake in mega merger with Keimed
The combined entity is valued at Rs 22,481 crore, positioning it as a leading retail health company in India. The merger aims to deliver substantial industry benefits and a pan-India presence, enhancing access to genuine medicines for 1.4 billion Indians within 24 hours.